Updated Jul 16, 2026
Zelnick Kaufman Beth is a corporate insider tracked by InsiderAlpha. No SEC Form 4 filings recorded in the last 90 days. Lifetime open-market sales: $670K.
Beth Zelnick Kaufman serves as the Chief Legal Officer at CorMedix Inc., a biopharmaceutical company focused on developing therapeutic products for serious diseases. She has been involved in various SEC filings related to her role within the company.
| Role | Chief Legal Officer |
|---|---|
| Notability | 20/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-02-07 | CRMD | CorMedix Inc. | A — Grant or award | 36.0K | $0.00 | |
| 2026-01-28 | CRMD | CorMedix Inc. | F — Tax withholding / forfeiture | 8.8K | $7.27 | $64K |
| 2026-01-28 | CRMD | CorMedix Inc. | A — Grant or award | 72.8K | $0.00 | |
| 2026-01-07 | CRMD | CorMedix Inc. | F — Tax withholding / forfeiture | 11.3K | $12.16 | $138K |
| 2025-09-09 | CRMD | CorMedix Inc. | S — Open-market sale | 400 | $12.82 | $5K |
| 2025-09-09 | CRMD | CorMedix Inc. | S — Open-market sale | 49.6K | $13.41 | $665K |
| 2025-09-09 | CRMD | CorMedix Inc. | M — Option exercise | 50.0K | $3.30 | $165K |
| 2025-08-29 | CRMD | CorMedix Inc. | F — Tax withholding / forfeiture | 8.9K | $14.83 | $132K |
| 2024-12-16 | CRMD | CorMedix Inc. | F — Tax withholding / forfeiture | 6.0K | $8.77 | $53K |
| 2024-12-16 | CRMD | CorMedix Inc. | M — Option exercise | 12.5K | — |
Beth Zelnick Kaufman serves as the Chief Legal Officer at CorMedix Inc., a biopharmaceutical company focused on developing therapeutic products for serious diseases. She has been involved in various SEC filings related to her role within the company.…
Recorded transactions: 0 open-market purchases () and 2 open-market sales ($670K) across all tracked filings.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Zelnick Kaufman Beth profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.